Brind.
  1. Tilray launched products through licensed retailers in Canada on May 28, 2026.
  2. Tilray, a company based in Canada, has begun exporting medical-grade cannabis products to markets in Europe.
  3. Tilray secured a partnership to distribute medical cannabis products in Italy, while Trump's administration considers reclassifying cannabis.
  4. Trump's administration is looking to reclassify marijuana, which could reshape the pot industry, involving Aurora Cannabis and TD Cowen.

Rate reduction affects market prices and sustainability for CanniMed.

1 report, 1 independent Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Rate reduction affects market prices and sustainability for CanniMed.

Who's involved

What this event is mainly about
CanniMed

Keep exploring

Part of

Trump's administration is looking to reclassify marijuana, which could reshape the pot industry, involving Aurora Cannabis and TD Cowen. All 2 developments

Within Tilray launched products through licensed retailers in Canada on May 28, 2026.

The entities involved

Coverage

Newest first; wire copies grouped
  • cbc.caVeterans with PTSD and chronic pain will have to pay up for pot prescriptions with new government policy | CBC News